Table 3.
Frequency (%) of clinical features in the three subgroups of patients with pathogenic variants in SETD1A
| % with clinical feature | |
|---|---|
| Number of patients | 6 |
| Clinical features | |
| Macrocephaly (HP:0000256) (absolute or relative) (%) | 83 |
| Short stature (HP:0004322) <10th centile (%) | 33 |
| Non-specific facial dysmorphisms HP:0001999 (%) | 100 |
| Joint laxity (HP:0001388) or hypermobility (%) | 50 |
| Sleep disturbance (HP:0002360) (%) | 66 |
| Brain MRI anomalies (HP:0002011) (%) | 17 |
| Mild—moderate neurodevelopmental delay (HP:0012758) (%) | 83 |
| Severe—profound neurodevelopmental delay (HP:0012758) (%) | 17 |
| Autistic spectrum features (HP:0000729) (%) | 50 |
| Seizures (HP:0001250) (%) | 17 |
| Congenital anomalies | 0 |